Three questions about the announcement of equity incentive scheme during the release of Ai ER

One side is the release of the first restricted stocks, jittery, while the volume rose, not afraid of throwing pressure ...　　In people are busy watching the first batch of the pioneering board lifted the tide to attack when the mouth, early plate strong impact of the stock of the eye (300015, shares bar) (300015, closing price 44.03 yuan) midday was injected with a dose of cardiac-9 million Stock options incentive plan released!　　However, some market participants to the "daily economic news" that the matter suspected of early disclosure, the initial stock release sensitive period of the introduction of stock option Incentive plan is suspected, and the incentive plan set the right threshold too low! Question one: The scheme was suspected in advance of the leak yesterday (November 1), Ai Seoul issued a midday notice said, the Company intends to award 9 million stock options, about the incentive plan signed when the total amount of company equity 3.37%, the marked for a-share, stock options of the right price of 41.58 yuan. The target is the company directors (excluding independent directors), senior managers, core managers, core technology (business) personnel and the relevant personnel who the Board deems necessary to motivate.　　The main right conditions are: in the period of validity of 2009 years of net profit base, 2011-2016 years relative to the 2009 net profit growth rate is not less than 25%, 50%, 75%, 100%, 130%, 160%. In response to the price of AI Seoul yesterday's rapid impact trading, until the end of the day until the end of the release of equity incentive announcements, the above people said that the Internet has a share incentive rumors, the noon before the announcement, may be forced out. It is understood that "AI Seoul to implement equity incentive" The news a few days ago has been spread over the network.　　Many investors have expressed great difficulty in understanding the major issue of the disclosure of the midday announcement. Some investors believe that it is in advance of the leak, only to lead to the stock price shocks after the foresight of the funds high position set; There are also investors that if the noon do not send the announcement, that the stock price rose more companies must be issued to clarify the announcement, then do not say also must say, things came out　　"Daily economic news," the investigation also found that the day yesterday in a mainstream financial media "hearsay" column on the stock rights incentive rumors reported.　　Question two: The publication time was suspected defective in the first restricted shares of the release of the sensitive period, love eye 9 million shares of the draft, many people in the industry said it was defective. According to the listing arrangements, November 1, the first public release of the company's shares in the release of the number of restricted sales of 9 million shares, the actual number of circulation can be listed 7.8 million shares.　　Data show that the 9 million shares of the lifting of the lift shares of 1 venture companies, 1 natural persons and 1 company executives. "If you want to push the equity incentive, there is no strict time rules, and when the company wants to push it." A senior market person said, "but the choice is now the time to launch, the stock price must be stimulating, of course, can also achieve the push of highPrice. "Daily Economic news" reporter survey further found that as early as more than a year ago, Ai ER has the idea of the introduction of equity incentives.　　Last September, Han Zhong, director of ophthalmology, Chief Financial officer and Secretary for Foreign Affairs, said that after the company went public, it would seriously study the equity incentive plans for senior executives, middle managers and technical backbone, and implement equity incentives when appropriate.　　Now, when is the "right time", the answer is clear. Question three: The right threshold is suspected too low data show that the eye was founded in 2003, is one of the fastest development of ophthalmic medical institutions.　　Company-owned industry for the medical profession in the Ophthalmic Medical Service subdivision industry, the main business to provide patients with a variety of ophthalmic disease diagnosis, treatment and medical optometry glasses.　　Earlier, Chen Bong Eye Chairman said that the listing behavior itself will not directly lead to an increase in employee income, but the company to raise funds in place will be the development of various business, profitable growth to form a strong support, so as to create favorable conditions for employee income growth. And the draft of equity incentive shows that the incentive involved in the incentives include directors, senior executives, core managers, core technology (business) personnel, such as total not more than 260 people.　　In this view, the equity incentive did fulfill the Chen Bong a year ago commitment.　　According to the provisions of the draft of equity incentive, the main conditions of the incentive object's right to do so are: based on 2009-year net profit, the net profit growth rate of 2011 ~2016 year is not less than 25%, 50%, 75%, 100%, 130% and 160% respectively. Public information shows that in 2009, the net profit of Ai ER's shareholders in listed companies was 92.4894 million yuan, up 50.72% from the same period in 2008. At the same time, the three quarterly bulletin also shows that the eye in 1 ~ September has achieved net profit of 88.027 million yuan, compared with the same period last year, the increase of 21.77%, has achieved 2009 net profit of 95.18%.　　It is noteworthy that the love Eye prospectus also disclosed that 2006-2008 years, the company's operating income composite annual growth rate of 51.55%, operating profit composite annual growth rate of 101.31%, outpatient service Volume composite annual growth rate of 29.68%, the operation of the composite annual growth rate of 42.38%. At the same time, according to the company's prospectus disclosed that last year's IPO funds will also be used to relocate 2 existing chain Eye Hospital, 8 new chain Eye Hospital, as well as the company's information management system project a total of 11 projects. Brokers analysts said that through listing financing to obtain more development opportunities, these should have a greater positive impact on corporate performance, rather than getting worse. In terms of the equity incentive right conditions announced by the unit, "this threshold means that for the next 6 years in 2011, the net profit growth in each of the year to 25%, 20%, 16.67%, 14.29%, 15%, 8.7% will be OK." The above market participants pointed out that"According to the current level of performance growth, this threshold is not the same!" Obviously, the equity incentives in the eye are not "golden handcuffs".